---
figid: PMC10413047__IJMM-52-2-05271-g01
figtitle: LncRNAs regulating the proliferation and apoptosis of NSCLC
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10413047
filename: IJMM-52-2-05271-g01.jpg
figlink: /pmc/articles/PMC10413047/figure/F2
number: F2
caption: Mechanisms of lncRNAs regulating the proliferation and apoptosis of NSCLC.
  (A) PIK3CD-AS2 inhibits p53 signaling by binding with p53 negative regulator YBX1.
  (B) MALAT1 inhibits p53 signaling by upregulating miR-185-5p and reducing the expression
  of MDM4. (C) UPLA1 facilitates Wnt/β-catenin signaling by binding to DSP. (D) XIST
  modulates miR-744 by serving as an endogenous competitive RNA, increasing RING1
  expression and enhancing the Wnt/β-catenin signaling pathway. (E) SLC16A1-AS1 affects
  overall survival and progression-free survival in NSCLC by regulating the RAS/RAF/MEK/ERK
  signaling pathway. lncRNA, long non-coding RNA; NSCLC, non-small cell lung cancer;
  PIK3CD-AS2, PIK3CD antisense RNA 2; YBX1, Y-box binding protein 1; MALAT1, metastasis-associated
  lung adenocarcinoma transcript 1; MDM4, murine double minute 4; UPLA1, lung adenocarcinoma
  related transcriptional-1; DSP, desmoplakin; XIST, candidate gene for X-inactivation
  center; miR, microRNA; RING1, really interesting new gene 1; lncRNA SLC16A1-AS1,
  SLC16A1 antisense transcript 1
papertitle: Long non-coding RNAs as potential therapeutic targets in non-small cell
  lung cancer (Review)
reftext: Peiyu Tang, et al. Int J Mol Med. 2023 Aug;52(2).
year: '2023'
doi: 10.3892/ijmm.2023.5271
journal_title: International Journal of Molecular Medicine
journal_nlm_ta: Int J Mol Med
publisher_name: D.A. Spandidos
keywords: lncRNA | NSCLC | therapeutic targets | biomarkers | drug resistance
automl_pathway: 0.8895508
figid_alias: PMC10413047__F2
figtype: Figure
redirect_from: /figures/PMC10413047__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10413047__IJMM-52-2-05271-g01.html
  '@type': Dataset
  description: Mechanisms of lncRNAs regulating the proliferation and apoptosis of
    NSCLC. (A) PIK3CD-AS2 inhibits p53 signaling by binding with p53 negative regulator
    YBX1. (B) MALAT1 inhibits p53 signaling by upregulating miR-185-5p and reducing
    the expression of MDM4. (C) UPLA1 facilitates Wnt/β-catenin signaling by binding
    to DSP. (D) XIST modulates miR-744 by serving as an endogenous competitive RNA,
    increasing RING1 expression and enhancing the Wnt/β-catenin signaling pathway.
    (E) SLC16A1-AS1 affects overall survival and progression-free survival in NSCLC
    by regulating the RAS/RAF/MEK/ERK signaling pathway. lncRNA, long non-coding RNA;
    NSCLC, non-small cell lung cancer; PIK3CD-AS2, PIK3CD antisense RNA 2; YBX1, Y-box
    binding protein 1; MALAT1, metastasis-associated lung adenocarcinoma transcript
    1; MDM4, murine double minute 4; UPLA1, lung adenocarcinoma related transcriptional-1;
    DSP, desmoplakin; XIST, candidate gene for X-inactivation center; miR, microRNA;
    RING1, really interesting new gene 1; lncRNA SLC16A1-AS1, SLC16A1 antisense transcript
    1
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CD-AS2
  - YBX1
  - TP53
  - TP63
  - TP73
  - MALAT1
  - DSP
  - DSPP
  - RING1
  - XIST
  - XIC
  - MIR744
  - SLC16A1-AS1
  - MDM4
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - KRAS
  - HRAS
  - NRAS
  - EPHB2
  - MAPK1
  - MAPK3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
---
